SCHEMBL844707

SCHEMBL844707

O=C(O)NC1CC[C@@H]2OC2C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TFPI2 P48307 5/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 1/20 0.41
GMNN O75496 1/20 0.41
PMP22 Q01453 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
THPO P40225 1/20 0.41
PPP1CA P62136 2/20 0.40
PPM1B O75688 2/20 0.36
PTPN1 P18031 2/20 0.36
PPP1CC P36873 2/20 0.36
PKM P14618 1/20 0.34
POLB P06746 1/20 0.32
PPP5C P53041 2/20 0.32
PPP2CA P67775 1/20 0.32
NPY4R P50391 1/20 0.32
EPHX2 P34913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468523 1.00 TFPI2 (0.41) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL9978357 1.00 TFPI2 (0.41) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL468432 1.00 TFPI2 (0.41) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL20679256 1.00 TFPI2 (0.41) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL15378131 1.00 TFPI2 (0.41) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL468430 1.00 TFPI2 (0.41) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL2116961 0.87 TFPI2 (0.37) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL15914393 0.87 TFPI2 (0.37) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL458523 0.87 TFPI2 (0.37) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL15914391 0.87 TFPI2 (0.37) TFPI2LMNAKDM4EGMNNPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576505-A1 PROCESS FOR THE PREPARATION OF PLEUROMUTILINS Nabriva Therapeutics AG (AT) 2013-04-10 EP disclosed
WO-2011146954-A1 PROCESS FOR THE PREPARATION OF PLEUROMUTILINS NABRIVA THERAPEUTICS AG (AT) 2011-12-01 WO disclosed